
RKTO P/E Ratio
P/E Ratio as of May 28, 2026: -2.10
Average-0.8800
Median-0.7800
Minimum-2.10
Maximum-0.7200
-2.10
1.29 (159.26%)past month
The P/E ratio for RKTO is -2.10 as of May 28, 2026. This represents a increase of 105.88% compared to its 12-month average P/E ratio of -1.02. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Hoth Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Hoth Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Hoth Therapeutics Inc to industry peers.
Hoth Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Hoth Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Hoth Therapeutics Inc to industry peers.
RKTO P/E Ratio Insights
See Hoth Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in RKTO
Order type
Buy in
Order amount
Est. shares
0 shares
RKTO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| May 1, 2026 | $0.7311 | -0.80 |
| Apr 1, 2026 | $0.5474 | -0.60 |
| Mar 2, 2026 | $1.02 | -0.96 |
| Feb 2, 2026 | $0.8765 | -0.82 |
| Jan 2, 2026 | $1.07 | -1.01 |
RKTO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -2.10 | +125.81% |
| 2025 | -0.93 | +75.47% |
| 2024 | -0.53 | +278.57% |
| 2023 | -0.14 | -81.08% |
| 2022 | -0.74 | -26.00% |
| 2021 | -1.00 | — |
FAQs About Hoth Therapeutics Inc (RKTO) P/E ratio
The latest P/E ratio of RKTO is -2.10, as of May 28, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Hoth Therapeutics Inc’s last 12-month average P/E ratio is -1.02, compared to its current P/E ratio of -2.10. This reflects a increase of 105.88%.
Hoth Therapeutics Inc’s current P/E ratio of -2.10 is higher than its last 12-month average P/E of -1.02. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Hoth Therapeutics Inc’s average P/E ratio over the last 3 years is -0.65. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Hoth Therapeutics Inc’s average P/E ratio over the last 5 years is -0.84. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.